You have no items in your shopping cart.
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 59.15 KDa. Observed: 85-100 KDa, reducing conditions
Human
Ala24-Lys580
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26.69 KDa. Observed: 57-66 KDa, reducing conditions
Human
Ala24-Pro247
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.1 KDa. Observed: 17-33 KDa, reducing conditions
Human
Thr20-Ala143
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 41.78 KDa. Observed: 46 KDa, reducing conditions
Human
Ser20-Pro396
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.9 KDa. Observed: 15 KDa, reducing conditions
Human
Gly21-Val142
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 60.75 KDa. Observed: 90 KDa, reducing conditions
Human
Cys24-Pro575
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.18 KDa. Observed: 35 KDa, reducing conditions
Human
Cys26-Phe223
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.88 KDa. Observed: 20 KDa, reducing conditions
Human
Gln16-Pro162
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.88 KDa. Observed: 18-33 KDa, reducing conditions
Human
Asp23-Lys213
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 52.48 KDa. Observed: 68 KDa, reducing conditions
Human
Glu33-Ile488
C-6His
10 μg, 50 μg, 1 mg, 500 μg
